Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
The new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can move more quickly from complex genomic and multiomic data to actionable insight Included in the new platform, latest DRAGEN update expands access to Illumina's...
Covered in this story
What has happened since
- Illumina is down 1.4% since this was published, 6 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ILMN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Illumina →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.